PNC-27

PNC-27 functions by binding to the HDM-2 protein, inducing apoptosis in cancer cells. This peptide is a synthetic construct derived from a segment of the p53 protein, a critical regulator in cell cycle and apoptosis. Research into PNC-27 began as scientists sought novel approaches to target cancer cells more specifically and effectively. Over time, its potential to selectively induce programmed cell death in malignant cells spurred further exploration in labs worldwide. It is also being studied for its potential effects on various tumor types. Today, it is primarily studied for its effects on:

• Cancer therapy
• Selective apoptosis induction
• HDM-2 protein interactions
• Tumor targeting
• Cell cycle regulation

Efforts are ongoing to explore its synergistic effects with other cancer treatments.

PeptideSource editorial · Updated Jul 18, 2026